The Mannich base of Thiozolidine-2,4-dione derivatives has come to lime light due to their various pharmacological activities. Thiazolidine-2,4-dione is an extensively explored heterocyclic nucleus for designing of novel agents implicated for a wide variety of pathophysiological conditions, that is, diabetes, diabetic complications, cancer, arthritis, inflammation, microbial infection, and melanoma. In present work, synthesis quinoline attached imidazoline derivative using (3 + 2) cyclo-addition via imine of quinoline and TosMIC. These derivatives were converted to Mannich bases of thiozolidine-2,4-dione using Knoevenagel condensation. The sulfonamide analogues of thiozolidine-2,4-Dione were also synthesized and characterized by using alkylation conditions.
Introduction
Thiazolidine-2,4-dione (TZD) is a vital nucleus in heterocyclic chemistry. TZD shows multidirectional pharmacological activities such as antioxidant [1] , antihyperglycemic (glitazone drugs) [2] [3], antibacterial and anti-fungal [4] , anticancer [5] , antimicrobial, antitubercular [6] , anti-arthritic [7] , diabetic & diabetic complications [8] [9] , anti-inflammatory activity [10] [11] and antiplasmodial activity [12] . Due to various pharmacological actions of TZD derivatives, researchers keep on huge interest in synthesis of new TZD derivatives by using various synthetic methods and carry out clinical trials for achieving lead target.
Nowadays, diabetes is a major metabolic disorder on human beings throughout tives, many scientists have developed various routes for synthesis.
Om Silakari et al. [2] developed different TZD derivatives and evolutes of their biological activity. The various pharmacological activity of Thiazolidine-2,4-dione was shown in Figure 1 .
Various approaches have been developed for synthesis of thiazolidine-2,4-dione and there are many active sites for exploring new analogues.
Thiazolidine-2,4-dione nucleus numbering is assigned as given below.
As a part of research work, we synthesize novel Mannich base of thiazolidine-2,4-dione and sulfonamide analogues using an effective and feasible process compared to other approaches and designed to make easy to scale up.
We strongly believe these analogues are biologically active. 
Materials and Methods
All reagents and starting material were procured from commercial sources (Aldrich, Alfa Aesar) and solvents, such as THF, DMF and toluene, which were thoroughly dried before use. THF and toluene were dried using sodium metal and Benzophenone, and DMF was dried using CaH. The synthesized analogues were fully characterized using Analytical methods like IR, NMR (Bruker). The melting points were recorded using on a WRS-1A digital Melting Point Apparatus without correction. Infrared spectra were taken using an AVATAR 370 FT-IR spectrometer. 1 
HNMR,
13 CNMR spectra were recorded with a Bruker spectrometer operating at 400 MHz with Trimethylsilane reference and values were recorded in ppm. The progress of reaction was monitored using TLC system and I 2 spray and KMnO 4 TLC strain. The crude compounds were purified using column chromatography (100 -200 mesh silica) and Combi Flash Chromatography. The hydrogenolysis process was carried out using parr shaker.
Objective of Research
Current Research work is related to develop novel synthetic route for synthesis of the Novel mannich bases of thiazolidine-2,4-dione, sulfonamide analogues and thoroughly characterized. The scaffolds of 3-(Amine substituted methyl)-
thiazolidine-2,4-dione (8a-f) were synthesized and characterized.
Experimental Methods
Current research work, we prepared below compounds and described in step wise manner.
oxy)methylene)thiazolidine-2,4-dione (6). 
Scheme
Reaction Conditions:
Step 1: Molecular sieves, Toluene, 0˚C, 10 h, Step 2: TOSMIC/K 2 CO 3 , 0˚C, 16 h, Step 3: 5% Pd(OH) 2 , H 2 , 70 Psi, 3 h, Step 4: 2-bromo-1,1-dimethoxyethane, K 2 CO 3 /DMF, 5 h, Step 5: thiazolidine-2,4-dione, Piperdine, 90˚C, 6 h, Step 6: Paraformaldehyde/2˚ Amine, Sc(OTf) 3 , EtOH, 90˚C, 8 h.
Step 7: NaH, DMF, 0˚C, 5 h.
Reaction mechanism for Step 2: The Reaction mechanism of step 2 was shown in Figure 2 .
Step 1: (Z)-N-((8-(benzyloxy)quinolin-5-yl)methylene)-4-(trifluoromethyl)aniline (2) : 
Molecular sieves Toluene
Step 1
Step 2
Step 3
Step 4
Step 5 Step 2: (2) (15 g, 0.036 mol) was dissolved in Dry DMF (80 mL) and cooled to 0 ˚C. To that dried K 2 CO 3 (15 g. 108 mol) and Toluene methyl isocyanide (7.02 g, 0.036 mol) was added and warm to room temperature and stirred for 16 h. The progress of reaction was monitored by TLC. After completion, reaction mixture was poured in ice cold water (100 mL) and extracted with EtOAc (3 × 100 mL). The organic layer was separated and washed with brine solution, dried over anhydrous 1 HNMR (d 6 -DMSO, 400 MHz): 6.5 (brs, 1H),
017 mol) in Dry DMF (70 mL) was added K 2 CO 3 (9.7 g, 0.07 mol, 4 eq) and stirred at rt for 30 min. To that a solution of 2-bromo-1, 1-dimethoxyethane (1.2 eq) in DMF (20 mL) was added dropwise at 0˚C and stirred for 5h. The progress of reaction was monitored by TLC. After completion, reaction mixture was filtered on celite bed and washed with DMF (10 mL). The Reaction mixture was poured in ice cold water (200 mL) and stirred for 20 min. The reaction mixture was acidified with aqNaHSO 3 Step 6 Table 1 . Step 7: General procedure for -3-
3-((4-oxopiperidin-1-yl)methyl)-5-(2-((5-(1-(4-(trifluoromethyl)phenyl)-1H-imidazol-5-yl)quinolin-8-yl)oxy)ethylidene)thiazolidine-2,4-dione (7a):
ethylidene) thiazolidine-2,4-dione (500 mg, 1.08 mmol) in Dry DMF(5 mL) was added NaH (3 eq) at 0˚C under N 2 atm and stirred for 1 h. To that derivative of sulfonyl chloride (1.1 eq) was added and stirred for 5 -8 h. The progress of reaction was monitored by TLC. The reaction mixture was poured in aq sat NaHCO 3 and stirred for 15 min. The a.q layer was extracted with 10% MeOH-CHCl 3 (3 × 25 ml) and dried over anhydrous Na 2 SO 4 , filtered and evaporated under vacuum to give crude product. The crude product was purified by Column chromato- Table 2 . 
Conclusion
In current research work, we successfully synthesized and characterized Mannich bases of quinoline attached imidazoline containing thiozolidine-2,4-dione derivatives and sulfonamide analogues. In step 2, cyclization was achieved in good yield. In step 4, aldehyde was isolated with good yield.
Step 7 & 8 avoid te- We are planning to make these derivatives check for biological evolution and details will include in next journal.
